Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Dansk
English
Søg efter indhold i Region Hovedstadens forskningsportal
Forside
Hospitaler/Afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Ching-Hon Pui
, Jun J Yang
, Stephen P Hunger
, Rob Pieters
, Martin Schrappe
, Andrea Biondi
, Ajay Vora
, André Baruchel
, Lewis B Silverman
,
Kjeld Schmiegelow
, Gabriele Escherich
, Keizo Horibe
, Yves C M Benoit
, Shai Izraeli
, Allen Eng Juh Yeoh
, Der-Cherng Liang
, James R Downing
, William E Evans
, Mary V Relling
, Charles G Mullighan
Afdeling for Børn og Unge
920
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Acute Lymphoblastic Leukemia
100%
Childhood Acute Lymphoblastic Leukemia
100%
Collaborative Study
37%
Philadelphia Chromosome
25%
Genetic Polymorphism
12%
Quality of Life
12%
Treatment Strategy
12%
High-resolution
12%
Improved Outcomes
12%
Cure Rate
12%
Tyrosine Kinase Inhibitor
12%
Targeted Therapy
12%
Genetic Abnormalities
12%
Personalized Treatment
12%
Genome-wide Analysis
12%
Collaborative Research
12%
English Literature
12%
Drug Toxicity
12%
Long-term Survival Rate
12%
Committee Chair
12%
Genetic Determinants of Drug Resistance
12%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Philadelphia 1 Chromosome
18%
Adolescence
18%
Genetics
18%
Quality of Life
9%
Long Term Survival
9%
Survival Rate
9%
Targeted Therapy
9%
Tyrosine-Kinase Inhibitor
9%
Genome Wide Association Study
9%
Genetic Polymorphism
9%
Drug Resistance
9%
Leukemia in Children
9%
Drug Toxicity
9%
Ethnic Difference
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Philadelphia 1 Chromosome
18%
Survival Rate
9%
Drug Resistance
9%
Protein Tyrosine Kinase Inhibitor
9%
Long Term Survival
9%
Drug Toxicity
9%